VH
Vesica Health, Inc.
SEC filingBiotechnology · Irvine, CA
Amount raised$4.5Msold at filing
Total offering$4.6M$163K still open
Investors in the raise12count reported to the SEC
FiledMar 17, 2026first sale Mar 3, 2026
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Christopher ThibodeauExecutive Officer, Director
Jan GroenDirector
Mark McDonoughDirector
Joseph SolleeDirector
Laura CabaExecutive Officer
Executive officers, directors and promoters as listed on the Form D.